Abstract
Renewed efforts are underway in the pharmaceutical industry to address the growing problem of antibiotic resistant pathogens. With this rededication to novel antibiotic discovery, new tools and technologies are being deployed to understand critical therapeutic intervention points in bacterial metabolism.